Type 2 diabetes mellitus, the most frequent subtype of diabetes, is a disease characterized by high levels of blood glucose (hyperglycaemia). It arises from a resistance to and relative deficiency ...

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.

Frias JP, Nauck MA, Van J, et al. Efficacy and safety of LY3298176, a dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled, phase 2 trial.

Similar to the findings of CAPPP and ASCOT-BPLA, the ALLHAT demonstrated an ACE inhibitor’s superiority over thiazides in reducing the rate of new-onset diabetes. However, the trial did note ...

Interleukin 1 (IL-1) is a 17 kDa protein highly conserved through evolution and is a key mediator of inflammation, fever and the acute-phase response. IL-1 has important functions in the innate ...

Diabetes mellitus is a group of metabolic diseases ... In the other, much more prevalent category (type 2 diabetes), the cause is a combination of resistance to insulin action and an inadequate ...